GURUFOCUS.COM » STOCK LIST » Basic Materials » Agriculture » Marrone Bio Innovations Inc (NAS:MBII) » Definitions » Other Stockholders Equity

Marrone Bio Innovations (Marrone Bio Innovations) Other Stockholders Equity : $-0.00 Mil (As of Mar. 2022)


View and export this data going back to 2013. Start your Free Trial

What is Marrone Bio Innovations Other Stockholders Equity?

Marrone Bio Innovations's Other Stockholders Equity for the quarter that ended in Mar. 2022 was $-0.00 Mil.

Marrone Bio Innovations's quarterly Other Stockholders Equity declined from Sep. 2021 ($0.00 Mil) to Dec. 2021 ($-0.00 Mil) but then increased from Dec. 2021 ($-0.00 Mil) to Mar. 2022 ($-0.00 Mil).

Marrone Bio Innovations's annual Other Stockholders Equity increased from Dec. 2019 ($0.00 Mil) to Dec. 2020 ($0.00 Mil) but then declined from Dec. 2020 ($0.00 Mil) to Dec. 2021 ($-0.00 Mil).


Marrone Bio Innovations Other Stockholders Equity Historical Data

The historical data trend for Marrone Bio Innovations's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Marrone Bio Innovations Other Stockholders Equity Chart

Marrone Bio Innovations Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Marrone Bio Innovations Quarterly Data
Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Marrone Bio Innovations Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity


Marrone Bio Innovations Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Marrone Bio Innovations's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Marrone Bio Innovations (Marrone Bio Innovations) Business Description

Traded in Other Exchanges
N/A
Address
7780-420 Brier Creek Parkway,, Raleigh, NC, USA, 27617
Marrone Bio Innovations Inc is a US-based agricultural company engaged in the discovery, development and sale of innovative biological products for crop protection, crop health and crop nutrition. The company produces bio-based pest management and plant health products such as Biopesticides, Bioinsecticides, Bionematicides, Biofungicides, Biostimulants and Bionutrition, among others. It generates key revenue from the sales of Marrone products, mainly Regalia, Grandevo and Venerate.
Executives
Pamela G Marrone director, officer: CEO and President C/O MARRONE BIO INNOVATIONS, INC., 2121 SECOND STREET, A-107, DAVIS CA 95618
Ladon Johnson officer: Interim CFO C/O MARRONE BIO INNOVATIONS, INC. 7780-420 BRIER CREEK PARWAY RALEIGH NC 27617-7882
Ardsley Ridgecrest Partners Fund, L.p. other: See Footnote (1) 262 HARBOR DRIVE, 4TH FLOOR, STAMFORD CT 06902
Suping (sue) Cheung officer: Chief Financial Officer C/O QUICKLOGIC CORPORATION, SUNNYVALE CA 94089
Matti Tiainen officer: SVP, International Sales C/O MARRONE BIO INNOVATIONS, INC. 1540 DREW AVENUE DAVIS CA 95618
Lara L Lee director C/O MARRONE BIO INNOVATIONS, INC., 1540 DREW AVENUE, DAVIS CA 95618
Kevin Helash director, officer: Chief Executive Officer C/O MARRONE BIO INNOVATIONS, INC. 1540 DREW AVENUE DAVIS CA 95618
Ardsley Advisory Partners Gp Llc other: See Footnotes(1)(2) 262 HARBOR DRIVE, 4TH FLOOR, STAMFORD CT 06902
Ospraie Management, Llc director, 10 percent owner, other: (See Remarks) 437 MADISON AVENUE, 28TH FLOOR, NEW YORK NY 10022
Ospraie Management, Inc. director, 10 percent owner, other: (See Remarks) 320 PARK AVENUE, 27TH FLOOR, NEW YORK NY 10022
Ospraie Holding I, L.p. director, 10 percent owner, other: (See Remarks) 320 PARK AVENUE, 27TH FLOOR, NEW YORK NY 10022
Dwight Anderson director, 10 percent owner, other: (See Remarks) C/O OSPRAIE MANAGEMENT, LLC, 320 PARK AVENUE, 27TH FLOOR, NEW YORK NY 10022
Ardsley Healthcare Fund, L.p. other: See Footnote (1) C/O ARDSLEY PARTNERS I GP, LLC, 262 HARBOR DRIVE, STAMFORD CT 06902
Ospraie Ag Science Llc director, 10 percent owner, other: (See Remarks) C/O DWIGHT ANDERSON 437 MADISON AVENUE, 28TH FLOOR NEW YORK NY 10022
Van Herk Investments B.v. 10 percent owner LICHTENAUERLAAN 30 ROTTERDAM P7 3062ME